[go: up one dir, main page]

SG11202110137VA - Benzodiazepine derivatives as rsv inhibitors - Google Patents

Benzodiazepine derivatives as rsv inhibitors

Info

Publication number
SG11202110137VA
SG11202110137VA SG11202110137VA SG11202110137VA SG11202110137VA SG 11202110137V A SG11202110137V A SG 11202110137VA SG 11202110137V A SG11202110137V A SG 11202110137VA SG 11202110137V A SG11202110137V A SG 11202110137VA SG 11202110137V A SG11202110137V A SG 11202110137VA
Authority
SG
Singapore
Prior art keywords
benzodiazepine derivatives
rsv inhibitors
rsv
inhibitors
benzodiazepine
Prior art date
Application number
SG11202110137VA
Inventor
Kaicheng Zhu
Kevin Mcgrath
Solymar Negretti-Emmanuelli
Adam Szymaniak
Jianming Yu
In Kim
Yat OR
Original Assignee
Enanta Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enanta Pharm Inc filed Critical Enanta Pharm Inc
Publication of SG11202110137VA publication Critical patent/SG11202110137VA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202110137VA 2019-03-18 2020-03-17 Benzodiazepine derivatives as rsv inhibitors SG11202110137VA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962819915P 2019-03-18 2019-03-18
US201962821094P 2019-03-20 2019-03-20
PCT/US2020/023135 WO2020190935A1 (en) 2019-03-18 2020-03-17 Benzodiazepine derivatives as rsv inhibitors

Publications (1)

Publication Number Publication Date
SG11202110137VA true SG11202110137VA (en) 2021-10-28

Family

ID=72514103

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202110137VA SG11202110137VA (en) 2019-03-18 2020-03-17 Benzodiazepine derivatives as rsv inhibitors

Country Status (15)

Country Link
US (3) US11254664B2 (en)
EP (1) EP3941525A4 (en)
JP (1) JP7558189B2 (en)
KR (1) KR20210138684A (en)
CN (1) CN113710276B (en)
AU (1) AU2020240024B2 (en)
BR (1) BR112021018335A2 (en)
CA (1) CA3133300A1 (en)
IL (1) IL286363A (en)
MX (1) MX2021011144A (en)
PH (1) PH12021552201A1 (en)
SG (1) SG11202110137VA (en)
TW (1) TWI872055B (en)
UY (1) UY38614A (en)
WO (1) WO2020190935A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10208081B2 (en) 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
US9957281B2 (en) 2015-07-22 2018-05-01 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as RSV inhibitors
BR112020006334A2 (en) 2017-09-29 2020-09-24 Enanta Pharmaceuticals, Inc. combination of pharmaceutical agents such as rsv inhibitors
BR112021018335A2 (en) * 2019-03-18 2021-11-23 Enanta Pharm Inc Benzodiazepine derivatives as RSV inhibitors
GB201911944D0 (en) 2019-08-20 2019-10-02 Reviral Ltd Pharmaceutical compounds
GB201915273D0 (en) * 2019-10-22 2019-12-04 Reviral Ltd Pharmaceutical compounds
AR129003A1 (en) 2022-04-07 2024-07-03 Enanta Pharm Inc HETEROCYCLIC ANTIVIRAL COMPOUNDS
WO2023211997A1 (en) 2022-04-27 2023-11-02 Enanta Pharmaceuticals, Inc. Antiviral compounds

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH573928A5 (en) 1973-07-30 1976-03-31 Crc Ricerca Chim
IT1087017B (en) 1977-10-18 1985-05-31 Ravizza Spa PROCESS FOR THE PREPARATION OF A 7-CHLORO-5- (2-CHLOROPHENYL) -BENZODIAZE PINONE
CA1332410C (en) 1984-06-26 1994-10-11 Roger M. Freidinger Benzodiazepine analogs
FR2641280B1 (en) 1988-12-29 1994-01-21 Roussel Uclaf NOVEL 2,4-DIOXO 2,3,4,5-TETRAHYDRO 1H-1,5-BENZODIAZEPINE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE AS MEDICAMENTS
US5571809A (en) 1989-04-20 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. The treatment of HIV-1 infection using certain pyridodiazepines
EP0538945A1 (en) 1991-10-24 1993-04-28 Glaxo Group Limited Benzodiazepine derivatives, and their use as antagonists of gastrin and/or cholecystokinin
GB9201180D0 (en) 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
JPH07505155A (en) 1992-03-24 1995-06-08 メルク　シヤープ　エンド　ドーム　リミテツド 3-Ureido-substituted benzodiazepine-2-ones with cholecystokinin and/or gastrin antagonistic activity and their use in therapy
GB9307833D0 (en) 1993-04-15 1993-06-02 Glaxo Inc Modulators of cholecystokinin and gastrin
EP0703222A1 (en) 1993-05-13 1996-03-27 Yoshitomi Pharmaceutical Industries, Ltd. 3-aminoazepine compound and pharmaceutical use thereof
DE60042425D1 (en) 1999-04-30 2009-07-30 Univ Michigan Use of benzodiazepines for the treatment of autoimmune diseases, inflammation, neoplasia, viral infections and atherosclerosis
DE10153348A1 (en) 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituted benzo (b) azepin-2-one compounds
JP2004043456A (en) 2002-05-24 2004-02-12 Yamanouchi Pharmaceut Co Ltd Medicine containing benzazepine derivative or its salt as active component
CA2482838A1 (en) 2002-05-31 2003-12-11 Eisai Co., Ltd. Pyrazole compounds and pharmaceutical compositions containing the compound
JP4719466B2 (en) 2002-09-20 2011-07-06 アロー セラピューティクス リミテッド Benzodiazepine derivatives and pharmaceutical compositions containing them
KR20050085535A (en) 2002-12-11 2005-08-29 파마시아 앤드 업존 캄파니 엘엘씨 Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds
GB0312365D0 (en) 2003-05-30 2003-07-02 Univ Aston Novel 3-substituted-1, 4-benzodiazepines
WO2005042530A1 (en) 2003-10-30 2005-05-12 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0406279D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
GB0406282D0 (en) 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Therapeutic compounds
US20070293482A1 (en) 2004-03-19 2007-12-20 Novartis Pharmaceuticals Corporation Process for Preparing Benzodiazepines
WO2006041970A2 (en) 2004-10-08 2006-04-20 Abbott Biotechnology Ltd. Treatment of respiratory syncytial virus (rsv) infection
AU2006208043B2 (en) 2005-01-25 2012-09-20 Synta Pharmaceuticals Corp. Thiophene compounds for inflammation and immune-related uses
EP2041156B1 (en) 2006-07-13 2013-11-20 Achillion Pharmaceuticals, Inc. 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
WO2008059042A1 (en) 2006-11-17 2008-05-22 Smithkline Beecham Corporation 2-carboxy thiophene derivatives as anti viral agents
UY32099A (en) 2008-09-11 2010-04-30 Enanta Pharm Inc HEPATITIS C SERINA PROTEASAS MACROCYCLIC INHIBITORS
US20100278835A1 (en) 2009-03-10 2010-11-04 Astrazeneca Uk Limited Novel compounds 660
US8232246B2 (en) 2009-06-30 2012-07-31 Abbott Laboratories Anti-viral compounds
US8999969B2 (en) 2009-07-09 2015-04-07 Gilead Sciences, Inc. Anti-RSV compounds
DK2496582T3 (en) 2009-11-05 2016-03-21 Glaxosmithkline Llc Benzodiazepine-BROMDOMAeNEINHIBITOR.
WO2011112186A1 (en) 2010-03-10 2011-09-15 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis c
US8450350B2 (en) 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
WO2011151651A1 (en) 2010-06-03 2011-12-08 Arrow Therapeutics Limited Benzodiazepine compounds useful for the treatment of hepatitis c
BR112013001553B1 (en) 2010-07-22 2021-01-12 Gilead Sciences, Inc. antiviral compounds for the treatment of paramyxoviridae infections and pharmaceutical compositions comprising them
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
TWI501967B (en) 2010-12-16 2015-10-01 Janssen R&D Ireland Azaindoles as respiratory syncytial virus antiviral agents
TWI527814B (en) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 Azabenzimidazoles as respiratory syncytial virus antiviral agents
TWI530495B (en) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 Benzimidazole respiratory syncytial virus inhibitors
TWI515187B (en) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 Indoles as respiratory syncytial virus antiviral agents
TWI541241B (en) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 Imidazopyridines as respiratory syncytial virus antiviral agents
TWI530489B (en) 2011-03-22 2016-04-21 必治妥美雅史谷比公司 Bis(fluoroalkyl)-1,4-benzodiazepine compound
JP6122868B2 (en) 2011-12-22 2017-04-26 ギリアード サイエンシーズ， インコーポレイテッド Pyrazolo [1,5-A] pyrimidine as an antiviral agent
DE102012101659A1 (en) 2012-02-29 2013-08-29 Aicuris Gmbh & Co. Kg Salts of a dihydroquinazoline derivative
EP3276332A3 (en) 2012-06-14 2018-04-18 Sony Corporation Information processing apparatus, information processing method, and information processing program
EP2864325A1 (en) 2012-06-15 2015-04-29 Janssen Sciences Ireland UC 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with benzimidazoles as respiratory syncytial virus antiviral agents
JP2015519385A (en) 2012-06-15 2015-07-09 ヤンセン・アールアンドデイ・アイルランド Novel 4-substituted 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted by benzimidazole as RS virus antiviral agents
CN104736530A (en) 2012-08-23 2015-06-24 艾丽奥斯生物制药有限公司 Compounds for the treatment of paramoxyvirus viral infections
US9427442B2 (en) 2012-09-21 2016-08-30 Bristol-Myers Squibb Company Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds
CN104797569A (en) 2012-09-21 2015-07-22 百时美施贵宝公司 Substituted 1,5-benzodiazepinone compounds
JP2015529252A (en) 2012-09-21 2015-10-05 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ Fluoroalkyl-1,4-benzodiazepinone compounds
CA2884491C (en) 2012-10-16 2021-08-31 Abdellah Tahri Rsv antiviral compounds
JP6383735B2 (en) 2013-01-28 2018-08-29 ヤンセン・サイエンシズ・アイルランド・ユーシー Quinoxalinone and dihydroquinoxalinone as antiviral agents for RS virus
TWI638815B (en) 2013-02-15 2018-10-21 英商葛蘭素史克智慧財產發展有限公司 Heterocyclic amides as kinase inhibitors (I)
US9815811B2 (en) 2013-03-14 2017-11-14 Curadev Pharma, Pvt. Ltd. Inhibitors of the kynurenine pathway
JO3603B1 (en) 2013-05-17 2020-07-05 Janssen Sciences Ireland Uc Sulfamoyl pyrolamide derivatives and their use as medicines to treat hepatitis B
EA201592075A1 (en) 2013-06-26 2016-05-31 Алиос Биофарма, Инк. SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND THEIR ANALOGUES
HK1225716A1 (en) 2013-08-21 2017-09-15 Alios Biopharma, Inc. Antiviral compounds
AR099134A1 (en) 2014-01-24 2016-06-29 Hoffmann La Roche PROCEDURE FOR THE PREPARATION OF N - [(3-AMINOOXETAN-3-IL) METHYL] -2- (1,1-DIOXO-3,5-DIHIDRO-1,4-BENZOTIAZEPÍN-4-IL) -6-METIL- QUINAZOLÍN-4-AMINA
TWI678369B (en) 2014-07-28 2019-12-01 美商基利科學股份有限公司 Thieno[3,2-d]pyrimidine, furo[3,2-d]pyrimidine, and pyrrolo[3,2-d]pyrimidines useful for treating respiratory syncitial virus infections
EP3177299A4 (en) 2014-08-05 2018-04-04 Alios Biopharma, Inc. Combination therapy for treating a paramyxovirus
KR20170058921A (en) 2014-10-10 2017-05-29 풀모사이드 리미티드 Novel 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivative
US10160772B2 (en) 2014-12-18 2018-12-25 Pulmocide Limited 5,6-dihydro-4H-benzo[b]thieno-[2,3-d]azepine derivatives
MA41614A (en) 2015-02-25 2018-01-02 Alios Biopharma Inc ANTIVIRAL COMPOUNDS
GB201506448D0 (en) 2015-04-16 2015-06-03 Univ Durham An antimicrobial compound
JP6779972B2 (en) 2015-07-16 2020-11-04 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ N-[(3-amino-3-oxetanyl) methyl] -2- (2,3-dihydro-1,1-dioxide-1,4-benzo) for the treatment of respiratory syncytial virus (RSV) infections Crystal form of thiazepine-4 (5H) -yl) -6-methyl-4-quinazolineamine
US9957281B2 (en) 2015-07-22 2018-05-01 Enanta Pharmaceuticals, Inc. Benzodiazepine derivatives as RSV inhibitors
US10364468B2 (en) 2016-01-13 2019-07-30 Seven Bridges Genomics Inc. Systems and methods for analyzing circulating tumor DNA
CN108699077B (en) * 2016-01-15 2021-03-02 英安塔制药有限公司 Heterocyclic compounds as RSV inhibitors
EP3414239A2 (en) 2016-02-05 2018-12-19 Denali Therapeutics Inc. Inhibitors of receptor-interacting protein kinase 1
WO2017175000A1 (en) 2016-04-08 2017-10-12 Pulmocide Limited Compounds
WO2018129287A1 (en) 2017-01-06 2018-07-12 Enanta Pharmaceuticals, Inc. Heteroaryldiazepine derivatives as rsv inhibitors
CA3065368A1 (en) * 2017-02-16 2018-08-23 Enanta Pharmaceuticals, Inc. Processes for the preparation of benzodiazepine derivatives
WO2018226801A1 (en) 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
US10851115B2 (en) 2017-06-30 2020-12-01 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
US11091501B2 (en) 2017-06-30 2021-08-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
BR112020006334A2 (en) 2017-09-29 2020-09-24 Enanta Pharmaceuticals, Inc. combination of pharmaceutical agents such as rsv inhibitors
EP3710009B1 (en) 2017-11-13 2025-07-30 Enanta Pharmaceuticals, Inc. Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
WO2019094920A1 (en) 2017-11-13 2019-05-16 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as rsv inhibitors
CN109966244A (en) 2017-12-27 2019-07-05 天津耀辰实业发展有限公司 A kind of pharmaceutical composition containing Le Temowei
WO2019199908A1 (en) 2018-04-11 2019-10-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
BR112021018335A2 (en) * 2019-03-18 2021-11-23 Enanta Pharm Inc Benzodiazepine derivatives as RSV inhibitors
WO2021066922A1 (en) 2019-10-04 2021-04-08 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (en) 2020-01-24 2021-07-30 Enanta Pharm Inc HETEROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS
WO2021198981A1 (en) 2020-04-01 2021-10-07 Janssen Biopharma, Inc. Antiviral compounds and uses thereof

Also Published As

Publication number Publication date
EP3941525A4 (en) 2022-12-07
US20220227746A1 (en) 2022-07-21
UY38614A (en) 2020-10-30
WO2020190935A1 (en) 2020-09-24
US11912695B2 (en) 2024-02-27
US20240360117A1 (en) 2024-10-31
JP2022525893A (en) 2022-05-20
JP7558189B2 (en) 2024-09-30
AU2020240024B2 (en) 2025-06-26
CN113710276B (en) 2024-03-29
BR112021018335A2 (en) 2021-11-23
CN113710276A (en) 2021-11-26
TWI872055B (en) 2025-02-11
EP3941525A1 (en) 2022-01-26
CA3133300A1 (en) 2020-09-24
KR20210138684A (en) 2021-11-19
US20200299286A1 (en) 2020-09-24
MX2021011144A (en) 2022-01-18
AU2020240024A1 (en) 2021-10-14
US11254664B2 (en) 2022-02-22
PH12021552201A1 (en) 2022-05-30
TW202102493A (en) 2021-01-16
IL286363A (en) 2021-10-31

Similar Documents

Publication Publication Date Title
ZA201904568B (en) Benzodiazepine derivatives as rsv inhibitors
IL286363A (en) Benzodiazepine derivatives as rsv inhibitors
EP3687543A4 (en) Combination pharmaceutical agents as rsv inhibitors
IL277455A (en) Aminopyrimidine derivatives as ctps1 inhibitors
GB201905265D0 (en) Inflammasome inhibition
SG11202103823PA (en) Aminopyrimidine/pyrazine derivatives as ctps1 inhibitors
IL279452B (en) Pyrazole derivatives as malt1 inhibitors
IL279453B (en) Pyrazole derivatives as malt1 inhibitors
ES3031576T3 (en) Jak1 selective kinase inhibitor
IL292093A (en) Thienopyrimidones as trpa1 inhibitors
IL292095A (en) Thienopyrimidones as trpa1 inhibitors
IL288472A (en) Tetracyclic compounds as cdc7 inhibitors
EP4025564A4 (en) Nitrification inhibitors
ZA202100140B (en) Pyridopyrimidinone derivatives for use as axl inhibitors
GB201919213D0 (en) Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds
HK40098388A (en) Jak1 selective inhibitors
HK40069065A (en) Jak1 selective kinase inhibitor
HK40055987B (en) Jak1 selective kinase inhibitor
HK40068930A (en) Substituted 5-cyclopropyl-1h-pyrazol-3-yl-amine derivatives as selective cdk12/13 inhibitors
HK40066175A (en) 2h-benzopyran derivatives as crac inhibitors
GB201908044D0 (en) Dopamine-B-Hydroxylase inhibitors
GB201905476D0 (en) MAPA4K4 Inhibitors
AU2019903269A0 (en) Nitrification Inhibitors
HK40042815A (en) Heterocyclic compounds as kinase inhibitors
HK1260101A1 (en) Heterocyclic compounds as rsv inhibitors